Author

Shirley Lomeli

University of California, Los Angeles

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Alan J. TackettiD· 1 shared Charity L. WashamiD· 1 shared Duah AlkamiD· 1 shared Gatien MoriceauiD· 1 shared Kanishka MannaiD· 1 shared Michael Scott RobesoniD· 1 shared Nathan L. AvarittiD· 1 shared Prashanthi DharanipragadaiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Alan J. TackettORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Proteogenomics analysis to identify acquired resistance-specific alterations in melanoma PDXs on MAPKi therapy

Kanishka Manna, Prashanthi Dharanipragada, Duah Alkam, Nathan L. Avaritt, Charity L. Washam, Michael Scott Robeson, Tung-Chin Chiang, Ricky D. Edmondson, Samuel Mackintosh, Zhentao Yang, Yan Wang, Shirley Lomeli, Gatien Moriceau, Stephanie D. Byrum, Roger S. Lo, Alan J. Tackett

The paper presents a proteogenomic approach to identify resistance-specific alterations in melanoma PDX models treated with MAPK inhibitors using custom curated databases.

bioRxiv · Feb 15, 2022 · PreprintBioinformatics